NCT06840886 2026-04-22A Study of PHST001 in Advanced Solid TumorsPheast TherapeuticsPhase 1 Recruiting272 enrolled
NCT04106219 2026-04-21A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory NeuroblastomaEli Lilly and CompanyPhase 1 Active not recruiting71 enrolled
NCT05429502 2025-10-10Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid TumorsNovartisPhase 1 Terminated12 enrolled
NCT04239092 2025-07-179-ING-41 in Pediatric Patients With Refractory Malignancies.Actuate Therapeutics Inc.Phase 1 Terminated40 enrolled
NCT03709680 2025-01-14Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsPfizerPhase 2 Active not recruiting128 enrolled
NCT04029688 2024-12-20A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid TumorsHoffmann-La RochePhase 1/2 Terminated38 enrolled 34 charts
NCT00437073 2015-10-15Brain Metastases In ErbB2-Positive Breast CancerGlaxoSmithKlinePhase 2 Terminated22 enrolled 8 charts